Results 71 to 80 of about 8,952 (190)

Systemic Disease Associations of Oral Lichenoid Disease: A Retrospective Case–Control Study

open access: yesOral Diseases, EarlyView.
ABSTRACT Objective To analyze the association between oral lichen planus (OLP), oral lichenoid lesions (OLL), and other comorbidities. Material and Methods A case–control study of 205 OLP, 96 OLL patients, and 301 age‐ and sex‐matched controls from Kuopio University Hospital was performed.
Mari Vehviläinen   +3 more
wiley   +1 more source

Therapeutic Management of a Case of Severe Psoriasis Coexistent with Bullous Pemphigoid in the Elderly

open access: yesPsoriasis: Targets and Therapy, 2023
Vito Di Lernia, Francesca Peccerillo, Elena Ficarelli Dermatology Unit, Azienda Unità Sanitaria Locale- IRCCS di Reggio Emilia, Reggio Emilia, ItalyCorrespondence: Vito Di Lernia, Dermatology Unit, Arcispedale Santa Maria Nuova, Azienda USL-IRCCS di ...
Di Lernia V, Peccerillo F, Ficarelli E
doaj  

Coexistence of psoriasis with bullous pemphigoid

open access: yesIndian Dermatology Online Journal, 2012
Psoriasis vulgaris and bullous pemphigoid (BP) represent two clinically well-characterized, chronic, inflammatory skin conditions. The concomitant occurrence of these two entities in a patient is rare.
Raghavendra Rao   +4 more
doaj   +1 more source

Dupilumab‐Induced Psoriasis in a Patient with Bullous Pemphigoid

open access: yes
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Nina Matthes   +6 more
wiley   +1 more source

A Serum N‐Glycan Ratio Associated With Disease Severity and Treatment Response in Psoriasis

open access: yesThe Journal of Dermatology, Volume 53, Issue 8, Page 1090-1098, August 2026.
ABSTRACT Psoriasis is a chronic, immune‐mediated inflammatory disease with heterogeneous manifestations. Reliable biomarkers reflecting disease severity and treatment response remain limited. Glycans—carbohydrate structures attached to proteins and lipids—play key roles in biological processes, contributing to functional specificity.
Kentarou Nishimura   +9 more
wiley   +1 more source

Dupilumab as a treatment for bullous pemphigoid in a liver transplant recipient: A case report

open access: yesSAGE Open Medical Case Reports
Bullous pemphigoid is a common subepidermal autoimmune bullous disease that affects the skin and mucous membranes. It is more prevalent in the elderly, often resulting in significant morbidity and mortality.
Sarah S. Rashid   +2 more
doaj   +1 more source

Study of Clinical Characteristics of Desquamative Gingivitis in 60 Patients in the North of Spain

open access: yesInternational Journal of Dental Hygiene, Volume 24, Issue 3, Page 404-410, August 2026.
ABSTRACT Objectives The aim of this study is to know the clinical characteristics of desquamative gingivitis (DG) in a Spanish population in order to make an early diagnosis of this sign and, therefore, the underlying systemic disease. Methods A cross‐sectional study was conducted.
Valeria Sanmartín‐Barragáns   +7 more
wiley   +1 more source

Complement-Activating Capacity of Autoantibodies Correlates With Disease Activity in Bullous Pemphigoid Patients

open access: yesFrontiers in Immunology, 2018
Background: Bullous pemphigoid is a subepidermal blistering skin disease, associated with autoantibodies to hemidesmosomal proteins, complement activation at the dermal-epidermal junction, and dermal granulocyte infiltration.
Roxana M. Chiorean   +9 more
doaj   +1 more source

Bullous Pemphigoid [PDF]

open access: yesJAMA Dermatology, 2013
Misha, Rosenbach   +2 more
openaire   +2 more sources

Pemphigoid: Bullous and Cicatricial

open access: yesDermatologic Clinics, 1990
Bullous pemphigoid is a blistering disease of the elderly that often is self-limited. It is apparently caused by autoantibodies against antigens of the basal cell hemidesmosome. There is apparently more than one antigen, but the most significant has a molecular weight of about 230 kD and the second most frequently detected antigen has a lower molecular
openaire   +2 more sources

Home - About - Disclaimer - Privacy